Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114963372 | 11496337 | 2 | F | 20150411 | 20160920 | 20150911 | 20160929 | EXP | US-009507513-1509USA006076 | MERCK | 62.00 | YR | F | Y | 102.00000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114963372 | 11496337 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 40 MG, QD | 10480 | MG | Y | 19558 | 40 | MG | TABLET | QD | |||
| 114963372 | 11496337 | 2 | SS | PRINIVIL | LISINOPRIL | 1 | Oral | 20 MG, QD | 10480 | MG | Y | 19558 | 20 | MG | TABLET | QD | |||
| 114963372 | 11496337 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, TID | Y | 0 | TABLET | TID | |||||||
| 114963372 | 11496337 | 4 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 0 | TABLET | ||||||||||
| 114963372 | 11496337 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
| 114963372 | 11496337 | 6 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG, Q4H | U | 0 | 50 | MG | Q4H | ||||||
| 114963372 | 11496337 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 0.5 MG TID, PRN | U | 0 | |||||||||
| 114963372 | 11496337 | 8 | C | MINIPRESS | PRAZOSIN HYDROCHLORIDE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 114963372 | 11496337 | 9 | C | REMERON | MIRTAZAPINE | 1 | Oral | 30 MG, QD | U | 0 | 30 | MG | TABLET | QD | |||||
| 114963372 | 11496337 | 10 | C | MELATONIN | MELATONIN | 1 | Oral | 3 MG, FREQUENCY REPORTED AS QHS (AT BED TIME) | U | 0 | 3 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114963372 | 11496337 | 1 | Hypertension |
| 114963372 | 11496337 | 3 | Osteoarthritis |
| 114963372 | 11496337 | 4 | Rheumatoid arthritis |
| 114963372 | 11496337 | 5 | Prophylaxis |
| 114963372 | 11496337 | 6 | Back pain |
| 114963372 | 11496337 | 7 | Schizoaffective disorder |
| 114963372 | 11496337 | 8 | Hypertension |
| 114963372 | 11496337 | 9 | Depression |
| 114963372 | 11496337 | 10 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114963372 | 11496337 | HO |
| 114963372 | 11496337 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114963372 | 11496337 | Cerebellar infarction | |
| 114963372 | 11496337 | Dizziness | |
| 114963372 | 11496337 | Fall | |
| 114963372 | 11496337 | Renal failure | |
| 114963372 | 11496337 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114963372 | 11496337 | 1 | 20140723 | 20150410 | 0 | |
| 114963372 | 11496337 | 2 | 20150412 | 0 | ||
| 114963372 | 11496337 | 3 | 20140515 | 20150411 | 0 | |
| 114963372 | 11496337 | 5 | 20140515 | 20150411 | 0 | |
| 114963372 | 11496337 | 6 | 20110630 | 0 | ||
| 114963372 | 11496337 | 7 | 20130101 | 0 | ||
| 114963372 | 11496337 | 8 | 20130101 | 0 | ||
| 114963372 | 11496337 | 9 | 20130101 | 0 | ||
| 114963372 | 11496337 | 10 | 20130101 | 0 |